FES-Rowing Versus Zoledronic Acid to Improve Bone Health in Spinal Cord Injury (SCI)
Status:
Terminated
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
This is a research study to determine the effects of functional electrical stimulation (FES)
rowing and a drug called zoledronic acid in bone health. The investigators hoped to learn if
zoledronic acid treatment will increase bone mineral density in persons with chronic spinal
cord injury (SCI) who received it. The investigators also want to find out if zoledronic acid
is safe for persons with SCI to take without causing too many side effects.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Antonio Lazzari
Collaborators:
Massachusetts General Hospital Spaulding Rehabilitation Hospital United States Department of Defense VA Boston Healthcare System